BibTex RIS Kaynak Göster

Bir Olgu Sunumu: Siprofloksasin Tedavisi Sonrası Gelişen Trombositoz

Yıl 2015, Cilt: 5 Sayı: 3, 155 - 158, 11.12.2015

Ali Tamer , Oğuz Karabay Ahmet Genç

Öz

Trombositoz tombosit sayısının 400.000/mm3 üzerinde olması olarak tanımlanır. İlaçlar sekonder trombositoz (ST) etyolojisinde yer almaktadır. Bu sunumda siprofloksasin tedavisi sırasında ekstrem trombositoz gelişen 23 yaşındaki bayan olguyu sunmayı amaçladık.

Anahtar Kelimeler

Trombositoz Siprofloksasin

Kaynakça

  • Finsterer J, Kotzailias N. Thrombocytosis under ciprofloxacin and tazobactam/piperacillin. Platelets 2003; 14: 329-331.
  • Wiwanitkit V. Extreme thrombocytosis: what are the etiologies? Clin Appl Thromb Hemost. 2006; 12: 85–87.
  • Yang CJ, Hwang JJ, Hung JY, Chong IW, Huang MS. Extreme thrombocytosis under the treatment by amoxicillin/ clavulanate. Pharm World Sci. 2006; 28: 326–328.
  • Yangco BG, Kenyon VS, Halkias KD, Bogel JA, Toney JF, Chmel H. Oral ciprofloxacin treatment of infections in geriatric patients. Clin Ther. 1989; 11: 503-510.
  • Harrison CN, Bareford D, Butt N, Campbell P, Conneally E, Drummond M, et al. Guideline for investigation and management of adults and children presenting with a thrombocytosis. Br J Haematol. 2010; 149: 352-375.
  • Osovsky M, Tamary H, Merlob P. Neonatal thrombocytosis following G-CSF treatment. Clinical Toxicology 2007; 45: 801–802.
  • Chen HC, Wang CY, Wang CS. Marked thrombocytosis during treatment with ceftazidime for pulmonary infection. Pharm World Sci. 2008; 30: 70–72.
  • Frye JL, Thompson DF. Drug-induced thrombocytosis. J Clin Pharm Ther 1993; 18: 45-48.
  • Tonbul A, Uras N, Tayman C, Halici T, Polat A, Mansur Tatli M. Thrombocytosis associated with enoxaparin: A very rare cause in newborns. Platelets. 2010; 21: 300-302.
  • Nako Y, Tachibana A, Fujiu T, Tomomasa T, Morikawa A. Neonatal thrombocytosis resulting from the maternal use of non-narcotic antischizophrenic drugs during pregnancy Arch Dis Child Fetal Neonatal Ed. 2001; 84: 198-200.
  • Parry MF, Jacobs B, Scully B, Neu HC. Thrombocytosis: an acute-phase reactant, not an adverse reaction to the new beta-lactam antibiotics. Diagn Microbiol Infect Dis. 1984; 2: 229-231.
  • -
  • Bertino J, Fish D. The Safety Profile of the Fluoroquinolones. Clinical therapeutics 2000; 22: 798-817.

Yıl 2015, Cilt: 5 Sayı: 3, 155 - 158, 11.12.2015

Ali Tamer , Oğuz Karabay Ahmet Genç

Öz

Kaynakça

  • Finsterer J, Kotzailias N. Thrombocytosis under ciprofloxacin and tazobactam/piperacillin. Platelets 2003; 14: 329-331.
  • Wiwanitkit V. Extreme thrombocytosis: what are the etiologies? Clin Appl Thromb Hemost. 2006; 12: 85–87.
  • Yang CJ, Hwang JJ, Hung JY, Chong IW, Huang MS. Extreme thrombocytosis under the treatment by amoxicillin/ clavulanate. Pharm World Sci. 2006; 28: 326–328.
  • Yangco BG, Kenyon VS, Halkias KD, Bogel JA, Toney JF, Chmel H. Oral ciprofloxacin treatment of infections in geriatric patients. Clin Ther. 1989; 11: 503-510.
  • Harrison CN, Bareford D, Butt N, Campbell P, Conneally E, Drummond M, et al. Guideline for investigation and management of adults and children presenting with a thrombocytosis. Br J Haematol. 2010; 149: 352-375.
  • Osovsky M, Tamary H, Merlob P. Neonatal thrombocytosis following G-CSF treatment. Clinical Toxicology 2007; 45: 801–802.
  • Chen HC, Wang CY, Wang CS. Marked thrombocytosis during treatment with ceftazidime for pulmonary infection. Pharm World Sci. 2008; 30: 70–72.
  • Frye JL, Thompson DF. Drug-induced thrombocytosis. J Clin Pharm Ther 1993; 18: 45-48.
  • Tonbul A, Uras N, Tayman C, Halici T, Polat A, Mansur Tatli M. Thrombocytosis associated with enoxaparin: A very rare cause in newborns. Platelets. 2010; 21: 300-302.
  • Nako Y, Tachibana A, Fujiu T, Tomomasa T, Morikawa A. Neonatal thrombocytosis resulting from the maternal use of non-narcotic antischizophrenic drugs during pregnancy Arch Dis Child Fetal Neonatal Ed. 2001; 84: 198-200.
  • Parry MF, Jacobs B, Scully B, Neu HC. Thrombocytosis: an acute-phase reactant, not an adverse reaction to the new beta-lactam antibiotics. Diagn Microbiol Infect Dis. 1984; 2: 229-231.
  • -
  • Bertino J, Fish D. The Safety Profile of the Fluoroquinolones. Clinical therapeutics 2000; 22: 798-817.
Toplam 13 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Makaleler
Yazarlar

Ali Tamer

Oğuz Karabay Bu kişi benim

Ahmet Genç Bu kişi benim

Yayımlanma Tarihi 11 Aralık 2015
Gönderilme Tarihi 6 Aralık 2015
Yayımlandığı Sayı Yıl 2015 Cilt: 5 Sayı: 3

Kaynak Göster

AMA Tamer A, Karabay O, Genç A. Bir Olgu Sunumu: Siprofloksasin Tedavisi Sonrası Gelişen Trombositoz. Sakarya Tıp Dergisi. Aralık 2015;5(3):155-158.
 Kapak Resmi İndir

30703

SMJ'de yayınlanan makaleler, Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı kapsamında lisanslanır